Ann: Shareholder Update, page-2

Good to see a bit of fighting spirit,,, always interesting when someone else wants in or to control the game plan,,, I only came in for the catalyst of positive trial results,, Obviously missed the Primary end point and treatment couldn't compete with normal standard of care,, actually sounds like in combination with standard care, covered and bandaged with treatment inclusive,, the wound results were significantly improved..

Is there not a market for bandages and dressings to be permeated at the point of manufacture with the treatment?

If these guys move toward the cancer end of the spectrum ,,, they wont have anywhere near enough $$ , I'm in one in Phase IB and to date costs are $43m....